JCR Pharmaceuticals Co., Ltd.
4552.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥78,740 | ¥62,506 | ¥59,892 | ¥74,810 |
| - Cash | ¥15,621 | ¥13,180 | ¥13,196 | ¥15,513 |
| + Debt | ¥40,105 | ¥40,105 | ¥38,105 | ¥32,392 |
| Enterprise Value | ¥103,224 | ¥89,431 | ¥84,801 | ¥91,689 |
| Revenue | ¥12,793 | ¥8,569 | ¥7,192 | ¥9,223 |
| % Growth | 49.3% | 19.1% | -22% | – |
| Gross Profit | ¥10,788 | ¥6,174 | ¥2,818 | ¥6,546 |
| % Margin | 84.3% | 72.1% | 39.2% | 71% |
| EBITDA | ¥4,088 | ¥67 | -¥5,179 | ¥739 |
| % Margin | 32% | 0.8% | -72% | 8% |
| Net Income | ¥2,256 | -¥546 | -¥4,183 | ¥115 |
| % Margin | 17.6% | -6.4% | -58.2% | 1.2% |
| EPS Diluted | 18.5 | -4.48 | -33.8 | 0.94 |
| % Growth | 512.9% | 86.7% | -3,695.7% | – |
| Operating Cash Flow | – | ¥0 | ¥0 | ¥0 |
| Capital Expenditures | – | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | – | ¥0 | ¥0 | ¥0 |